Quartette (Teva) is FDA filed for Contraception - 16-Aug-2012

Teva Women’s Health, Inc., a U.S.-based subsidiary of Teva Pharmaceutical Industries Ltd, has announced that the FDA has accepted for filing its New Drug Application (NDA) for Quartette (levonorgestrel/ethinyl estradiol tablets and ethinyl estradiol tablets) for Contraception.

Related News

Related Women's Health and Obs/Gyn Information

Women's Health and Obs/Gyn Clinical Guidelines

Antenatal and postnatal mental health

NICE

Antenatal care: Routine care for the healthy pregnant woman

NICE

Women's Health and Obs/Gyn Clinical Trials

Bone Healing in Healthy and Post-menopausal Osteoporotic Women

Clinicaltrials.gov 26 March 2013

TMMR Register Study (TMMR-RS)

Clinicaltrials.gov 19 March 2013

Women's Health and Obs/Gyn Medical Journal Abstracts

Influence of Mu-Opioid Receptor Variant on Morphine Use and Self-Rated Pain Following Abdominal Hysterectomy

The Journal of Pain 03 June 2013

Interpretation and Management of Hepatic Abnormalities in Pregnancy

Clinical Gastroenterology and Hepatology 28 May 2013

Women's Health and Obs/Gyn Medical Apps

Obstetics and Gynecology On Call

£0.69

Women's Health

Free

Related Women's Health and Obs/Gyn Drugs

Back to top

Latest News

17 Jun 2013
16 Jun 2013
16 Jun 2013